期刊文献+

抑瘤素M在膝关节骨关节炎中的表达

Expression of oncostatin M in knee osteoarthritis
原文传递
导出
摘要 目的检测抑瘤素M(OSM)在骨关节炎(OA)和正常滑膜组织中的表达差异,探讨OSM在骨关节炎发病中的作用。方法术中留取33例OA严重病变组、10例OA轻微病变组、8例正常对照组的滑膜组织。采用实时定量PCR技术检测各组膝关节滑膜组织中OSM的表达,免疫组织化学法检测各组滑膜组织中OSM的分布与表达。结果在膝关节滑膜组织中,OA严重病变组、OA轻微病变组和正常对照组均能检测出OSM阳性表达且与病情严重程度呈正相关,差异有统计学意义(P<0.05)。OA轻微病变组与对照组比较差异无统计学意义(P>0.05)。结论 OA患者滑膜细胞高表达OSM与病情相关。OSM在骨关节炎的发病过程中起到重要作用。 Objective To investigate the difference of OSM expression between OA and the normal synovial membrane,and to discuss its function in the pathogenesis of knee osteoarthritis.Method OSM expression was concurrently detected in synovial fluid samples from 33 patients with severe OA,10 patients with slight OA and 8 patients with normal disciform meniscus.We performed quantitative real-time PCR to determine all the genual synovium OSM gene expression levels.The distribution of OSM in all genual synovium was detected by immunohistochemical technology.Results OSM was found in all patients′ synovial fluid.The expression level of OSM had a positive correlation with the severity of OA(P〈0.05).There was no significant difference in expression of OSM between patients with slight OA and patients with normal disciform meniscus(P〉0.05).Conclusion OA synovial cells may have a higher level of OSM,which is related to the course of disease.OSM plays an important role in the pathogenesis process of osteoarthritis.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第5期80-83,87,共5页 Journal of Shandong University:Health Sciences
基金 山东省优秀中青年科学家科研奖励基金(2001BB1DBA3)
关键词 骨关节炎 滑膜 抑瘤素M 膝关节 Osteoarthritis Synovium Oncostatin M Knee joint
  • 相关文献

参考文献24

二级参考文献31

  • 1WANG Hai-jun,YU Chang-long,Kishi Hiroyuki,Motoki Kazumi,MAO Ze-bin,Muraguchi Atsushi.Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer[J].Chinese Medical Journal,2006(16):1365-1373. 被引量:20
  • 2段海清 张兆山 等.-[J].生物化学杂志,1997,3:259-263.
  • 3萨母布鲁克J 金冬雁译.分子克隆实验指南(第二版)[M].北京:科学出版社,1996.16-75.
  • 4Recht M P, Kramer J , Marcelis S, etal. Abnormalities of articular cartilage in the knee : analysis of available MR techniques [ J ]. Radiology, 1993,187 ( 2 ) :473-478.
  • 5Little C B, Hughes C E, Curtis C L, et al. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation[ J ]. Matrix Biol, 2002, 21 ( 3 ) : 271- 288.
  • 6Morten A K, Suzi H M, Claus Christiansen, et al. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity [ J ]. Arthritis Res Ther, 2008,10(3) : 63.
  • 7Collins-Racie L A, Flannery C R, Zeng W, et al. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage[J]. Matrix Biol, 2004,23(4): 219-230.
  • 8Rodriguez-Manzaneque J, Westling J, Thai S, et al. ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors [ J ]. Biochem Biophys Res Commun, 2002,293 (1) :501-508.
  • 9Tortorella M D, Liu R Q, Burn T, et al. Characterization of human aggrecanase 2 ( ADAMTS-5 ) : substrate specificity studies in comparison with aggrecanase 1 (ADAMTS-4) [J]. Matrix Biol, 2002,21 (6) :499-511.
  • 10Somerville R, Longpre J, Jungers K, et al. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1 [J]. J Biol Chem,2003,278(11) :9503-9513.

共引文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部